Replication of Theiler's virus requires NF-κB-activation: Higher viral replication and spreading in astrocytes from susceptible mice

GLIA

Volumn 56, Issue 9, 2008, Pages 942-953

  Kang, Min Hyung ^a   So, Eui Young ^a   Park, Hyesuk ^a   Kim, Byung S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Astrocytes; NF B; TMEV; Viral replication; Viral spreading

Indexed keywords

CYTOKINE; GREEN FLUORESCENT PROTEIN; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P105; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; C57BL 6 MOUSE; CELL NUCLEUS; CELL SPREADING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; FIBROBLAST; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFECTION RESISTANCE; INFECTION SENSITIVITY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; STRAIN DIFFERENCE; SWISS JAMES LAMBERT MOUSE; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; WILD TYPE;

ANIMALS; ASTROCYTES; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; CRICETINAE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NF-KAPPA B; THEILOVIRUS; VIRUS REPLICATION;

EID: 51349114281     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20668     Document Type: Article

References (57)

1. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
2. Aubert C, Chamorro M, Brahic M. 1987. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathogol 3:319-326.
3. Baeuerle PA, Baichwal VR. 1997. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65:111-137.
4. Barnes PJ, Karin M. 1997. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
5. Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma IM, others. 2007. A fourth IκB protein within the NF-κB signaling module. Cell 128:369-381.
6. Beg AA. 2002. Endogenous ligands of Toll-like receptors: Implications for regulating inflammatory and immune responses. Trends Immunol 23:509-512.
7. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
8. Binder JJ, Hoffman MA, Palmenberg AC. 2003. Genetic stability of attenuated mengovirus vectors with duplicate primary cleavage sequences. Virology 312:481-494.
9. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M. 2004. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J 23:4202-4210.
10. Bowman CC, Rasley A, Tranguch SL, Marriott I. 2003. Cultured astrocytes express toll-like receptors for bacterial products. Glia 43:281-291.
11. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. 2005. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360-374.
12. Carpentier PA, Williams BR, Miller SD. 2007. Distinct roles of protein kinase R, toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia 55:239-252.
13. Chamorro M, Aubert C, Brahic M. 1986. Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection. J Virol 57:992-997.
14. Chang JR, Zaczynska E, Katsetos CD, Platsoucas CD, Oleszak EL. 2000. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice Virology 278:346-360.
15. Dal Canto MC, Melvold RW, Kim BS, Miller SD. 1995. Two models of multiple sclerosis: Experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech 32: 215-229.
16. Fontana A, Constam D, Frei K, Koedel U, Pfister W, Weller M. 1996. Cytokines and defense against CNS infection. In: Ransohoff RM, Benveniste EN, editors. Cytokines and the CNS. Boca Raton, FL: CRC Press. pp 188-219.
17. Ghosh S, May MJ, Kopp EB. 1998. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
18. Gilmore TD, Herscovitch M. 2006. Inhibitors of NF-κB signaling: 785 and counting. Oncogene 25:6887-6899.
19. Gregory D, Hargett D, Holmes D, Money E, Bachenheimer SL. 2004. Efficient replication by herpes simplex virus type 1 involves activation of the IκB kinase-IκB-p65 pathway. J Virol 78:13582-13590.
20. Guidotti LG, Chisari FV. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65-91.
21. Hoshino K, Sugiyama T, Matsumoto M, Tanaka T, Saito M, Hemmi H, Ohara O, Akira S, Kaisho T. 2006. IκB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440:949-953.
22. Hou W, So EY, Kim BS. 2007. Role of dendritic cells in differential susceptibility to viral demyelinating disease. PLoS Pathog 3:e124.
23. Inoue A, Choe YK, Kim BS. 1994. Analysis of antibody responses to predominant linear epitopes of Theiler's marine encephalomyelitis virus. J Virol 68:3324-3333.
24. Jelachich ML, Bandyopadhyay P, Blum K, Lipton HL. 1995. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology 209:437-444.
25. Jin YH, Mohindru M, Kang MH, Fuller AC, Kang B, Gallo D, Kim BS. 2007. Differential virus replication, cytokine production, and antigen- presenting function by microglia from susceptible and resistant mice infected with Theiler's virus. J Virol 81:11690-11702.
26. Karin M, Lin A. 2002. NF-κB at the crossroads of life and death. Nat Immunol 3:221-227.
27. Kim BS, Lyman MA, Kang BS, Kang HK, Lee HG, Mohindru M, Palma JP. 2001. Pathogenesis of virus-induced immune-mediated demyelination. Immunol Res 24:121-130.
28. Kim BS, Palma JP, Kwon D, Fuller AC. 2005. Innate immune response induced by Theiler's murine encephalomyelitis virus infection. Immunol Res 31:1-12.
29. Krug LT, Moser JM, Dickerson SM, Speck SH. 2007. Inhibition of NF-κB activation in vivo impairs establishment of Gammaherpesvirus latency. PLoS Pathogens 3:ell.
30. Kwon D, Fuller AC, Palma JP, Choi IH, Kim BS. 2004. Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-κB. Glia 45:287-296.
31. Lehrich JR, Arnason BG, Hochberg FH. 1976. Demyelinative myelopathy in mice induced by the DA virus. J Neuro Sci 29:149-160.
32. Lim BK, Shin JO, Lee SC, Kim DK, Choi DJ, Choe SC, Knowlton KU, Jeon ES. 2005. Long-term cardiac gene expression using a coxsackie-viral vector. J Mol Cell Cardiol 38:745-751.
33. Lin R, Heylbroeck C, Pitha PM, Hiscott J. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18:2986-2996.
34. Lipton HL, Kratochvil J, Sethi P, Dal Canto MC. 1984. Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology 34:1117-1119.
35. Lipton HL, Kumar AS, Trottier M. 2005. Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes. Virus Res 111:214-223.
36. Lorch Y, Friedmann A, Lipton HL, Kotler M. 1981. Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol 40:560-567.
37. Meffert MK, Baltimore D. 2005. Physiological functions for brain NF-κB. Trends Neurosci 28:37-43.
38. + T cell epitope region of Theiler's virus in resistant C57BL/6 mice is critical for anti-viral immune responses, viral persistence, and binding to the host cells. Virology 360:159-171.
39. Nakahira M, Ahn HJ, Park WR, Gao P, Tomura M, Park CS, Hamaoka T, Ohta T, Kurimoto M, Fujiwara H. 2002. Synergy of IL-12 and IL-18 for IFN-γ gene expression: IL-12-induced STAT4 contributes to IFN-γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 168:1146-1153.
40. Palma JP, Kim BS. 2001. Induction of selected chemokines in glial cells infected with Theiler's virus. J Neuroimmunol 117:166-170.
41. Palma JP, Kim BS. 2004. The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus. J Neuroimmunol 149:121-129.
42. Palma JP, Kwon D, Clipstone NA, Kim BS. 2003. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-κB activation: potential role for the initiation of demyelinating disease. J Virol 77:6322-6331.
43. Pullen LC, Park SH, Miller SD, Dal Canto MC, Kim BS. 1995. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J Immunol 155:4497-4503.
44. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
45. Rodriguez M, Leibowitz JL, Lampert PW. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 13:426-433.
46. Sato S, Reiner SL, Jensen MA, Roos RP. 1997. Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J Neuroimmunol 76:213-223.
47. Sha WC, Lion HC, Tuomanen EI, Baltimore D. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
48. Shaw-Jackson C, Michiels T. 1997. Infection of macrophages by Theiler's murine encephalomyelitis virus is highly dependent on their activation or differentiation state. J Virol 71:8864-8867.
49. Skias DD, Mm DE, Reder AT, Antel JP, Lancki DW, Fitch FW. 1987. Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J Immunol 138:3254-3258.
50. So EY, Kang MH, Kim BS. 2006. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. Glia 53:858-867.
51. Takano-Maruyama M, Ohara Y, Asakura K, Okuwa T. 2006. Leader (L) and L* proteins of Theiler's murine encephalomyelitis virus (TMEV) and their regulation of the virus' biological activities. J Neuroinflammation 3:19.
52. Takaoka A, Yanai H. 2006. Interferon signalling network in innate defence. Cell Microbiol 8:907-922.
53. Trottier M, Kallio, P, Wang W, Lipton HL. 2001. High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus. J Virol 75:7420-7428.
54. van Pesch V, van Eyll O, Michiels T. 2001. The leader protein of Theiler's virus inhibits immediate-early alphalbeta interferon production. J Virol 75:7811-7817.
55. Yauch RL, Palma JP, Yahikozawa H, Koh CS, Kim BS. 1998. Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J Virol 72:6169-6174.
56. Zhang L, Sato S, Kim JI, Roos RR 1995. Theiler's virus as a vector for foreign gene delivery. J Virol 69:3171-3175.
57. Zheng L, Calenoff MA, Dal Canto MC. 2001. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J Neuroimmunol 118:256-267.